Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers

被引：91
|
作者：
Michl, P
Downward, J
机构：
[1] Univ Ulm Klinikum, Innere Med Abt 1, D-89081 Ulm, Germany
[2] Canc Res UK, London Res Inst, Signal Transduct Lab, London, England
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2005年 / 43卷 / 10期
关键词：
Akt; protein kinase B; PI-3; kinase; gastrointestinal; tumor; signaling; survival; proliferation; apoptosis; metastasis;
D O I：
10.1055/s-2005-858638
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The lipid kinase phosphoinositide 3-OH kinase (PI3K) and its downstream target Akt, also known as protein kinase B (PKB), are crucial effectors in oncogenic signaling induced by various receptor-tyrosine kinases. In recent years, data are accumulating that PI3K/Akt signaling components are frequently altered in a variety of human malignancies. This review summarizes the major effects of PI3K/Akt signaling on proliferation, survival and resistance to apoptosis, angiogenesis and cell motility in gastrointestinal cancers. In addition, activation of PI3K/Akt by various growth factors, the modulation of downstream targets by Akt-induced phosphorylation as well as novel treatment strategies targeting this pathway in gastrointestinal tumors are discussed.
引用
收藏
页码：1133 / 1139
页数：7
相关论文
共 50 条
  • [41] Targeting PI3K/Akt signaling in prostate cancer therapy
    Mehrdad Hashemi
    Afshin Taheriazam
    Pouria Daneii
    Aria Hassanpour
    Amirabbas kakavand
    Shamin Rezaei
    Elahe Sadat Hejazi
    Maryam Aboutalebi
    Hamidreza Gholamrezaie
    Hamidreza Saebfar
    Shokooh Salimimoghadam
    Sepideh Mirzaei
    Maliheh Entezari
    Saeed Samarghandian
    Journal of Cell Communication and Signaling, 2023, 17 : 423 - 443
  • [42] Investigation of EGFR/pi3k/Akt signaling pathway in seminomas
    Guerra, F.
    Quintana, S.
    Giustina, S.
    Mendeluk, G.
    Jufe, L.
    Avagnina, M. A.
    Diaz, L. B.
    Palaoro, L. A.
    BIOTECHNIC & HISTOCHEMISTRY, 2021, 96 (02) : 125 - 137
  • [43] Stability Analysis of the PI3K–Akt–mTOR Signaling Pathway
    Sapega T.S.
    Guria G.T.
    Biophysics, 2020, 65 (2) : 259 - 267
  • [44] Role of SMO in the Activation of PI3K/AKT Signaling in DLBCL
    Vaghefi, Amineli
    Agarwal, Nitin K.
    Kunkalla, Kranthi
    Kim, Chae Hwa
    Tjendra, Youley
    Landgraf, Ralf
    Vega, Francisco
    LABORATORY INVESTIGATION, 2017, 97 : 382A - 382A
  • [45] Reactive oxygen species and PI3K/Akt signaling in cancer
    Yeon, Jin Seo
    Sun, Lee Hye
    Kyoung, Kim Eun
    Min, Ha Jung
    Whan, Kim Young
    SunSik, Bae
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 75 : S34 - S35
  • [46] PI3K/AKT signaling pathway and cancer: an updated review
    Martini, Miriam
    De Santis, Maria Chiara
    Braccini, Laura
    Gulluni, Federico
    Hirsch, Emilio
    ANNALS OF MEDICINE, 2014, 46 (06) : 372 - 383
  • [47] The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
    Matsuoka, Tasuku
    Yashiro, Masakazu
    CANCERS, 2014, 6 (03) : 1441 - 1463
  • [48] Inhibition of PI3K/Akt/mTOR Signaling by Natural Products
    Huang, Shile
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 967 - 970
  • [49] Special issue: PI3K/Akt signaling in human cancer
    Murugan, Avaniyapuram Kannan
    SEMINARS IN CANCER BIOLOGY, 2019, 59 : 1 - 2
  • [50] Role of PI3K/Akt signaling pathway in cardiac fibrosis
    Wuming Qin
    Linghui Cao
    Isaac Yaw Massey
    Molecular and Cellular Biochemistry, 2021, 476 : 4045 - 4059
12345